Omnicell Expands International Presence with Opening of Omnicell India Software Development Center


MOUNTAIN VIEW, CALIFORNIA – (COMMERCIAL THREAD) – Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced the opening of ‘a new software development center through its Indian subsidiary based in Bangalore, India. Omnicell’s new center will focus on product innovations to advance the company’s strategy to provide cloud-based infrastructure to support stand-alone pharmacy.

Bangalore Software Development Center will accelerate Omnicell’s cloud strategy and its suite of cloud-based hardware, software and technology services designed to empower healthcare providers, including hospitals, retail pharmacies and ‘other entities, improve quality, reduce costs, and increase human efficiency. Migrating to a single cloud-based platform and integrating pharmacy systems will allow healthcare organizations to navigate the complexities of medication management and achieve more robust, data-driven results.

Omnicell India’s new software development center will be led by Ved Singh, who joins Omnicell as Vice President, Software Engineering. Ved brings over 24 years of experience building products on cloud-based artificial intelligence platforms, enterprise software, and mobile applications. “We are excited about the opportunity to accelerate Omnicell’s cloud strategy, providing software to support integrated and interoperable solutions that will improve efficiency and patient outcomes across the continuum of care.” said Virad Gupta, who, as vice president of software applications and cloud platform, heads the company’s global software engineering organization. “Ved will play a pivotal role in delivering software services that will support the Omnicell Cloud platform, combining its experience in developing cloud-based products and platforms with scale-up teams. from zero. ”

Omnicell helps providers across the continuum of care realize the potential of autonomous pharmacy by replacing error-prone manual processes with smart technology and automated workflows. Through a powerful combination of hardware, software and technology services, delivered through a cloud platform, Omnicell’s medication management solutions help improve quality, reduce costs and increase human efficiency.

Visit our Recruitment site to learn more about opportunities to join the Bangalore-based team.

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy delivery model to dramatically improve outcomes and reduce costs. Through the Autonomous Pharmacy Vision, a combination of automation, intelligence and technology services, powered by a cloud-based data platform, Omnicell supports more efficient ways of managing medications across all settings. care settings. More than 7,000 facilities around the world use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable insights and improve patient safety. Over 50,000 institutional and retail pharmacies in North America and the UK leverage Omnicell’s innovative drug adherence and population health solutions to improve patient engagement and adherence prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.

OMNICELL is a registered trademark and the Omnicell logo is a trademark of Omnicell, Inc.

Forward-looking statements

Certain statements in this press release relate to future plans and objectives for Omnicell’s products and services. These statements are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results and other events may differ materially from those contemplated by forward-looking statements due to many factors that involve known and unknown material risks. and uncertainties. These risks and uncertainties include, among others, those described in the Risk Factors section of Omnicell’s most recent annual report on Form 10-K and in other documents filed by the Company with the Securities and Exchange Commission. Forward-looking statements should be viewed in light of these risks and uncertainties. Investors are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. Omnicell assumes no obligation to update these statements, whether as a result of changed circumstances, new information, future events or otherwise, except as required by law.

OMCL-G


Gordon K. Morehouse